Breakthrough in Cancer Gene Therapy: Nanoparticle-Based Approach for Neuropathic Pain Relief

Strategic Insights -

Research conducted by a team of scientists at Nantong University has yielded a promising breakthrough in cancer gene therapy, offering a novel approach to treating neuropathic pain. By leveraging lipid nanoparticles as a delivery system, the team demonstrated the effectiveness of targeting the dorsal root ganglion (DRG) to alleviate pain. The study's findings suggest that this method could potentially revolutionize the treatment of neuropathic pain, a debilitating condition affecting millions of people worldwide.

Key Takeaways:

  • A team of researchers at Nantong University has developed a novel approach to treating neuropathic pain using lipid nanoparticles as a delivery system.
  • The nanoparticles were designed to target the dorsal root ganglion (DRG) to effectively deliver conventional analgesics to the DRG and improve analgesic effect.
  • Results revealed that the nanoparticles extended the duration of action of the free analgesic from less than 6 hours to more than 24 hours.
  • The nanoparticles showed therapeutic superiority over conventional liposomes due to their good structural stability for a more sustained release kinetics.
  • The study found that the intravenously injected nanoparticles facilitated analgesic accumulation in the DRG in spared nerve injury and chemotherapy-induced neuropathic pain models.
  • The nanoparticles significantly improved the intensity of action for pain relief in a single or repeated treatments, ultimately relieving pain-related psychiatric comorbidities.
  • The researchers cited the need for more sustained release kinetics in conventional liposomes as a major limitation in current pain relief treatments.

Statistics:

  • The research concluded that the nanoparticles-based DRG-targeted delivery strategy through systemic injection is the first example of such a treatment approach.
  • The study found that the nanoparticles extended the duration of action of the free analgesic from less than 6 hours to more than 24 hours.
  • The researchers observed significant improvements in pain relief intensity in single or repeated treatments using the nanoparticles.

Sources:

  • Dorsal root ganglion-targeted analgesic delivery for effective relief of neuropathic pain. Materials Today Bio, 2025;33:102025.
  • Nantong University Reports Findings in Cancer Gene Therapy (Dorsal root ganglion-targeted analgesic delivery for effective relief of neuropathic pain). Nanotechnology Weekly. August 4, 2025; p 970.
  • NewsRx. Nantong University, Institute of Special Environmental Medicine, Nantong, People's Republic of China.